Bio-key International, Inc. (BKYI) Misses Q4 EPS by 35c

Bio-key International, Inc. (NASDAQ: BKYI) reported Q4 EPS of ($0.62), $0.35 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $1.76 million versus the consensus estimate of $1.74 million.

For earnings history and earnings-related data on Bio-key International, Inc. (BKYI) click here.

You May Also Be Interested In

• Broadcom credit risk measures rise amid AI financing deals
• X Financial (XYF) Tops Q2 EPS by 438c
• EHang Holdings (EH) Tops Q2 EPS by 110c